Successful treatment with cladribine in a patient with Rosai–Dorfman disease complicated by severe, prolonged marrow aplasia

Click to increase image sizeClick to decrease image size

Acknowledgements

We thank Edward Lowczowski from the Medical University of Lodz for editorial assistance and Aleksandra Samulska for technical assistance. We are grateful to the medical, nursing, and laboratory staff of the participating departments for their contributions to this study.

Author contributions

TR, EI-J, and PR conceived the case. TR and PR collected data and wrote the initial version of the manuscript. MB was responsible for histologic characterization. AG was responsible for diagnostic imaging. All authors agreed to the final version of the manuscript.

Ethics statement

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Consent form

Written informed consent was obtained from the patient.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.